PURPOSE: Fecal incontinence is a common disorder that can have devastating social and psychologic consequences. However, there are no long-term ideal solutions for such patients. Although loss of continence is multifactorial, the integrity of the internal anal sphincter (IAS) has particular significance. We previously described the development of 3-dimensional bioengineered constructs using isolated smooth muscle tissue from donor C57BL/6 IAS. We hypothesized that the bioengineered ring constructs would retain cellular viability and promote neovascularization upon implantation into a recipient mouse. METHODS: Internal anal sphincter ring constructs were surgically implanted into the subcutaneous tissue of syngeneic C57BL/6 mice and treated with either fibroblastic growth factor 2 (0.26 microg daily) or saline controls using a microosmotic pump. Internal anal sphincter constructs were harvested after 25 days (range, 23-26 days) and assessed morphologically and for tissue viability. RESULT: Gross morphology showed that there was no rejection. Rings showed muscle attachment to the back of the mouse with no sign of inflammation. Fibroblastic growth factor 2 infusion resulted in a significantly improved histologic score and muscle viability compared with the control group. CONCLUSIONS: Three-dimensional bioengineered IAS rings can be successfully implanted into the subcutaneous tissue of recipient mice. The addition of fibroblastic growth factor 2 led to improved muscle viability, vascularity, and survival. This approach may become a feasible option for patients with fecal incontinence. Copyright 2010 Elsevier Inc. All rights reserved.
PURPOSE: Fecal incontinence is a common disorder that can have devastating social and psychologic consequences. However, there are no long-term ideal solutions for such patients. Although loss of continence is multifactorial, the integrity of the internal anal sphincter (IAS) has particular significance. We previously described the development of 3-dimensional bioengineered constructs using isolated smooth muscle tissue from donor C57BL/6 IAS. We hypothesized that the bioengineered ring constructs would retain cellular viability and promote neovascularization upon implantation into a recipient mouse. METHODS: Internal anal sphincter ring constructs were surgically implanted into the subcutaneous tissue of syngeneic C57BL/6 mice and treated with either fibroblastic growth factor 2 (0.26 microg daily) or saline controls using a microosmotic pump. Internal anal sphincter constructs were harvested after 25 days (range, 23-26 days) and assessed morphologically and for tissue viability. RESULT: Gross morphology showed that there was no rejection. Rings showed muscle attachment to the back of the mouse with no sign of inflammation. Fibroblastic growth factor 2 infusion resulted in a significantly improved histologic score and muscle viability compared with the control group. CONCLUSIONS: Three-dimensional bioengineered IAS rings can be successfully implanted into the subcutaneous tissue of recipient mice. The addition of fibroblastic growth factor 2 led to improved muscle viability, vascularity, and survival. This approach may become a feasible option for patients with fecal incontinence. Copyright 2010 Elsevier Inc. All rights reserved.
Authors: Thomas Eschenhagen; Michael Didié; Felix Münzel; Pia Schubert; Karin Schneiderbanger; Wolfram-Hubertus Zimmermann Journal: Basic Res Cardiol Date: 2002 Impact factor: 17.165
Authors: S Perry; C Shaw; C McGrother; R J Matthews; R P Assassa; H Dallosso; K Williams; K R Brittain; U Azam; M Clarke; C Jagger; C Mayne; C M Castleden Journal: Gut Date: 2002-04 Impact factor: 23.059
Authors: J Leor; S Aboulafia-Etzion; A Dar; L Shapiro; I M Barbash; A Battler; Y Granot; S Cohen Journal: Circulation Date: 2000-11-07 Impact factor: 29.690
Authors: Eiichi A Miyasaka; Shreya Raghavan; Robert R Gilmont; Krittika Mittal; Sita Somara; Khalil N Bitar; Daniel H Teitelbaum Journal: Pediatr Surg Int Date: 2011-02 Impact factor: 1.827
Authors: Shreya Raghavan; Robert R Gilmont; Eiichi A Miyasaka; Sita Somara; Shanthi Srinivasan; Daniel H Teitelbaum; Khalil N Bitar Journal: Gastroenterology Date: 2011-04-02 Impact factor: 22.682
Authors: Shreya Raghavan; Eiichi A Miyasaka; Mohamed Hashish; Sita Somara; Robert R Gilmont; Daniel H Teitelbaum; Khalil N Bitar Journal: Am J Physiol Gastrointest Liver Physiol Date: 2010-06-17 Impact factor: 4.052